Overview

Dexmedetomidine Nebulization for Attenuation of Pressor Response to Laryngoscopy and Endotracheal Intubation in Sever Preeclamptic Patients

Status:
NOT_YET_RECRUITING
Trial end date:
2026-12-15
Target enrollment:
Participant gender:
Summary
Dexmedetomidine nebulization in sever preeclamptic patients
Phase:
NA
Details
Lead Sponsor:
Assiut University
Treatments:
Dexmedetomidine
Sodium Chloride